Eureka Therapeutics Announces Appointment Of Dr. Hanzhong Li As Senior Vice President Of Corporate Development
Eureka Therapeutics announces US FDA Clearance of IND Application for Phase 1/2 Trial of ET140202 ARTEMIS T-Cell Therapy, for the Treatment of Liver Cancer
